World Journal of Laparoscopic Surgery

Register      Login

VOLUME 12 , ISSUE 3 ( September-December, 2019 ) > List of Articles

CASE REPORT

Laparoscopic Ureterolysis without Omentoplasty in the Management of the Uropathy Secondary to Idiopathic Retroperitoneal Fibrosis

Miguel A Bergero, Patricio A Garcia Marchiñena, Guillermo Gueglio, Carlos David, Fernando Dipatto, Alberto Jurado

Citation Information : Bergero MA, Marchiñena PA, Gueglio G, David C, Dipatto F, Jurado A. Laparoscopic Ureterolysis without Omentoplasty in the Management of the Uropathy Secondary to Idiopathic Retroperitoneal Fibrosis. World J Lap Surg 2019; 12 (3):126-129.

DOI: 10.5005/jp-journals-10033-1377

License: CC BY-NC 4.0

Published Online: 22-03-2021

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Introduction: Obstructive uropathy (OU) secondary to idiopathic retroperitoneal fibrosis (IRF) is an infrequent disease, and the standard treatment has not been established. However, ureterolysis with ureteral intraperitonealization is an effective therapeutic alternative. We present the successful management of OU secondary to an IRF by laparoscopic ureterolysis without omentoplasty (LUWO). Materials and methods: A retrospective descriptive study of 5 patients with IRF treated with LUWO was performed. Results: The average age was 60.4 years. The average creatinine was 3.86 mg/dL. There were no intraoperative or major postoperative complications. In a follow-up period of 31.2 months, all patients are asymptomatic, with an average creatinine level of 1.52 without dialysis requirement. No patients required corticosteroid therapy after surgery. Conclusion: Laparoscopic ureterolysis without omentoplasty is a safe and feasible option to treat the OU caused by IRF that provides good results in the medium-term follow-up, as we describe it in our series of cases.


HTML PDF Share
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.